This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011 Apr;61(2):69–90.JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statistics2011Apr612699010.3322/caac.2010721296855Search in Google Scholar
Siegel, RL, Miller, KD, Fuchs, H, Jemal, A. Cancer Statistics, 2021. CA Cancer J Clin. 2021: 71: 7–33. https://doi.org/10.3322/caac.21654.SiegelRLMillerKDFuchsHJemalACancer Statistics, 2021202171733https://doi.org/10.3322/caac.2165410.3322/caac.2165433433946Search in Google Scholar
Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, et al. (eds). SEER cancer statistics review, 1975–2014, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017.HowladerNNooneAMKrapchoMMillerDBishopKKosaryCL(eds).National Cancer InstituteBethesda, MDhttps://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017.Search in Google Scholar
Bertuccio P, Rosato V, Andreano A, Ferraroni M, Decarli A, Edefonti V, et al. Dietary patterns and gastric cancer risk: a systematic review and meta-analysis. Ann Oncol Off J Eur Soc Med Oncol. 2013 Jun;24(6):1,450–8.BertuccioPRosatoVAndreanoAFerraroniMDecarliAEdefontiVDietary patterns and gastric cancer risk: a systematic review and meta-analysis2013Jun2461,450810.1093/annonc/mdt10823524862Search in Google Scholar
Ma J-L, Zhang L, Brown LM, Li J-Y, Shen L, Pan K-F, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 2012 Mar 21;104(6):488–92.MaJ-LZhangLBrownLMLiJ-YShenLPanK-FFifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality2012Mar2110464889210.1093/jnci/djs003330912922271764Search in Google Scholar
Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med. 2009 Jul 21;151(2):121–8.FuccioLZagariRMEusebiLHLaterzaLCennamoVCeroniLMeta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?2009Jul211512121810.7326/0003-4819-151-2-200907210-0000919620164Search in Google Scholar
Alix-Panabières C, Schwarzenbach H, Pantel K. Circulating tumor cells and circulating tumor DNA. Annu Rev Med. 2012;63:199–215.Alix-PanabièresCSchwarzenbachHPantelKCirculating tumor cells and circulating tumor DNA20126319921510.1146/annurev-med-062310-09421922053740Search in Google Scholar
Kohler C, Barekati Z, Radpour R, Zhong XY. Cell-free DNA in the circulation as a potential cancer biomarker. Anticancer Res. 2011 Aug;31(8):2,623–8.KohlerCBarekatiZRadpourRZhongXYCell-free DNA in the circulation as a potential cancer biomarker2011Aug3182,6238Search in Google Scholar
Jin H, Ma Y, Shen Q, Wang X. Circulating methylated DNA as biomarkers for cancer detection. Methylation – DNA RNA Histones Dis Treat [Internet]. 2012 Nov 28 [cited 2019 May 4]; Available from: https://www.intechopen.com/books/methylation-from-dna-rna-and-histones-to-diseases-and-treatment/circulating-methylated-dna-as-biomarkers-for-cancer-detection.JinHMaYShenQWangXCirculating methylated DNA as biomarkers for cancer detection2012Nov28[cited 2019 May 4]; Available from: https://www.intechopen.com/books/methylation-from-dna-rna-and-histones-to-diseases-and-treatment/circulating-methylated-dna-as-biomarkers-for-cancer-detection.10.5772/51419Search in Google Scholar
Alix-Panabieres, C., Schwarzenbach, H., & Pantel, K.. Circulating tumor cells and circulating tumor DNA. Annu Rev Med, 2012;63,199–215.Alix-PanabieresC.SchwarzenbachH.PantelK.Circulating tumor cells and circulating tumor DNA20126319921510.1146/annurev-med-062310-094219Search in Google Scholar
Ghossein, RA, Bhattacharya, S, Rosai, J. Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res. 1999;5:1,950–1,960.GhosseinRABhattacharyaSRosaiJMolecular detection of micrometastases and circulating tumor cells in solid tumors199951,9501,960Search in Google Scholar
Mocellin, S., Keilholz, U., Rossi, C. R., Nitti, D. Circulating tumor cells: the ‘leukemic phase’ of solid cancers. Trends Mol Med. 2006;12:130–139.MocellinS.KeilholzU.RossiC. R.NittiDCirculating tumor cells: the ‘leukemic phase’ of solid cancers20061213013910.1016/j.molmed.2006.01.00616488189Search in Google Scholar
Chimonidou, M., Strati, A., Tzitzira, A., Sotiropoulou, G., Malamos, N., Georgoulias, V., et al. DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells. Clin Chem. 2011;57:1,169–1,177.ChimonidouM.StratiA.TzitziraA.SotiropoulouG.MalamosN.GeorgouliasV.DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells2011571,1691,17710.1373/clinchem.2011.16590221700955Search in Google Scholar
Kohler, C., Barekati, Z., Radpour, R., Zhong, X. Y. Cell-free DNA in the circulation as a potential cancer biomarker. Anticancer Res. 2011;31:2,623–2,628.KohlerC.BarekatiZ.RadpourR.ZhongX. Y.Cell-free DNA in the circulation as a potential cancer biomarker2011312,6232,628Search in Google Scholar
Jin H, Ma Y, Shen Q, Wang X. Circulating methylated DNA as biomarkers for cancer detection. Methylation – DNA RNA Histones Dis Treat [Internet]. 2012 November 28 [cited 2019 May 4]; Available from: https://www.intechopen.com/books/methylation-from-dna-rna-and-histones-to-diseases-and-treatment/circulating-methylated-dna-as-biomarkers-for-cancer-detection.JinHMaYShenQWangXCirculating methylated DNA as biomarkers for cancer detection2012November28[cited 2019 May 4]; Available from: https://www.intechopen.com/books/methylation-from-dna-rna-and-histones-to-diseases-and-treatment/circulating-methylated-dna-as-biomarkers-for-cancer-detection.10.5772/51419Search in Google Scholar
Chen H-M, Fang J-Y. Epigenetic biomarkers for the early detection of gastrointestinal cancer. Gastrointest Tumors. 2014 May;1(4):201–8.ChenH-MFangJ-YEpigenetic biomarkers for the early detection of gastrointestinal cancer2014May14201810.1159/000380784466879626674521Search in Google Scholar
Karamitrousis EI, Balgkouranidou I, Xenidis N, Amarantidis K, Biziota E, Koukaki T, et al. Prognostic role of RASSF1A, SOX17 and Wif-1 promoter methylation status in cell-free DNA of advanced gastric cancer patients. Technol Cancer Res Treat. 2021 Jan–Dec;20:1533033820973279. doi: 10.1177/1533033820973279. PMID: 33928818; PMCID: PMC8113658.KaramitrousisEIBalgkouranidouIXenidisNAmarantidisKBiziotaEKoukakiTPrognostic role of RASSF1A, SOX17 and Wif-1 promoter methylation status in cell-free DNA of advanced gastric cancer patients2021Jan–Dec201533033820973279.10.1177/1533033820973279PMID: 33928818; PMCID: PMC8113658.811365833928818Open DOISearch in Google Scholar
Balgkouranidou I, Matthaios D, Karayiannakis A, Bolanaki H, Michailidis P, Xenidis N, et al. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients. Mutat Res. 2015 Aug;778:46–51.BalgkouranidouIMatthaiosDKarayiannakisABolanakiHMichailidisPXenidisNPrognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients2015Aug778465110.1016/j.mrfmmm.2015.05.00226073472Search in Google Scholar
Bu J, Lee TH, Jeong WJ, Poellmann MJ, Mudd K, Eun HS, et al. Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer. PLoS One. 2020 Dec 2;15(12):e0242145. doi: 10.1371/journal.pone.0242145. PMID: 33264292; PMCID: PMC7710035.BuJLeeTHJeongWJPoellmannMJMuddKEunHSEnhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer2020Dec21512e024214510.1371/journal.pone.0242145PMID: 33264292; PMCID: PMC7710035.771003533264292Open DOISearch in Google Scholar